<?xml version="1.0" encoding="UTF-8"?>
<p id="P23">Fomivirsen is given intravitreally. Its main indication is the treatment of CMV retinitis in patients with AIDS who have not benefited from or are intolerant of standard CMV therapies, or whose virus is resistant to ganciclovir and foscarnet.
 <sup>
  <xref ref-type="bibr" rid="R55">55</xref>-
  <xref ref-type="bibr" rid="R57">57</xref>
 </sup> The main adverse effect of fomivirsen is increased intraocular pressure and inflammation. Blurred vision, conjunctival hemorrhage, retinal detachment, and retinal edema are other adverse effects.
 <sup>
  <xref ref-type="bibr" rid="R55">55</xref>-
  <xref ref-type="bibr" rid="R57">57</xref>
 </sup>
</p>
